RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
NovaBay Pharmaceuticals Stock

NovaBay Pharmaceuticals Employees 2024

NovaBay Pharmaceuticals Employees

28

Ticker

NBY

ISIN

US66987P2011

WKN

A2ACBF

In 2024, NovaBay Pharmaceuticals employed 28 people, a 0% change from the 28 number of employees in the previous year.

NovaBay Pharmaceuticals Aktienanalyse

What does NovaBay Pharmaceuticals do?

NovaBay Pharmaceuticals Inc. is a California-based company specializing in the development and commercialization of healthcare infection treatment and prevention products. The company was founded in 2002 and focuses on developing and marketing products based on its patented antimicrobial technology. NovaBay Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining NovaBay Pharmaceuticals's Employee Base

NovaBay Pharmaceuticals's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding NovaBay Pharmaceuticals's operational capacity and future potential.

Year-to-Year Comparison

Assessing NovaBay Pharmaceuticals's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

NovaBay Pharmaceuticals's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in NovaBay Pharmaceuticals’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about NovaBay Pharmaceuticals stock

How many employees does NovaBay Pharmaceuticals have this year?

NovaBay Pharmaceuticals has 28 undefined employees this year.

How many employees did NovaBay Pharmaceuticals have compared to the previous year?

Compared to the previous year, NovaBay Pharmaceuticals had 0% more employees.

What impact did the number of employees have on the company NovaBay Pharmaceuticals?

The number of employees has a direct impact on the efficiency and productivity of NovaBay Pharmaceuticals. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of NovaBay Pharmaceuticals?

The number of employees can also have an impact on investors of NovaBay Pharmaceuticals, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of NovaBay Pharmaceuticals affect the company?

An increase in equity of NovaBay Pharmaceuticals can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in NovaBay Pharmaceuticals's equity affect the company?

A reduction in equity of NovaBay Pharmaceuticals can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of NovaBay Pharmaceuticals?

Some factors that can influence the equity of NovaBay Pharmaceuticals include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of NovaBay Pharmaceuticals so important for investors?

The equity of NovaBay Pharmaceuticals is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at NovaBay Pharmaceuticals influence the company?

The number of employees at NovaBay Pharmaceuticals can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at NovaBay Pharmaceuticals evolved in recent years?

In recent years, the number of employees at NovaBay Pharmaceuticals has changed by 0.

How many employees does NovaBay Pharmaceuticals currently have?

NovaBay Pharmaceuticals currently has 28 undefined employees.

Why is the number of employees important for investors of NovaBay Pharmaceuticals?

The number of employees is important for investors of NovaBay Pharmaceuticals as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can NovaBay Pharmaceuticals take to change the number of employees?

To change the number of employees, NovaBay Pharmaceuticals can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does NovaBay Pharmaceuticals pay?

Over the past 12 months, NovaBay Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, NovaBay Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of NovaBay Pharmaceuticals?

The current dividend yield of NovaBay Pharmaceuticals is .

When does NovaBay Pharmaceuticals pay dividends?

NovaBay Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of NovaBay Pharmaceuticals?

NovaBay Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of NovaBay Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is NovaBay Pharmaceuticals located?

NovaBay Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von NovaBay Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of NovaBay Pharmaceuticals from 11/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/16/2024.

When did NovaBay Pharmaceuticals pay the last dividend?

The last dividend was paid out on 11/16/2024.

What was the dividend of NovaBay Pharmaceuticals in the year 2023?

In the year 2023, NovaBay Pharmaceuticals distributed 0 USD as dividends.

In which currency does NovaBay Pharmaceuticals pay out the dividend?

The dividends of NovaBay Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von NovaBay Pharmaceuticals

Our stock analysis for NovaBay Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NovaBay Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.